Immunohistochemical profiling of brain metastases from breast cancer, focusing on ER, PR, HER2, and Ki-67, revealed specific correlations between tumor proliferation, time to metastasis, and neuroimaging features such as hemorrhage and lesion location. Here, ERBB2 is linked to breast carcinoma.